Structure

InChI Key GBBSUAFBMRNDJC-INIZCTEOSA-N
Smile CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
InChI
InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H17ClN6O3
Molecular Weight 388.82
AlogP 1.57
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 2.0
Polar Surface Area 91.76
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 27.0

Pharmacology

Action Mechanism of Action Reference
POSITIVE ALLOSTERIC MODULATOR GABA-A receptor; anion channel positive allosteric modulator FDA PubMed Wikipedia
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Ion channel Ligand-gated ion channel GABA-A receptor
- - - 102 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Sleep Apnea, Obstructive 2 D020181 ClinicalTrials
Anxiety Disorders 2 D001008 ClinicalTrials
Marijuana Abuse 1 D002189 ClinicalTrials

Related Entries

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
23.79
Nervous system disorders
22.81
General disorders and administration site conditions
16.02
Injury, poisoning and procedural complications
7.21
Gastrointestinal disorders
6.3
Cardiac disorders
3.17
Product issues
3.17
Vascular disorders
2.51
Skin and subcutaneous tissue disorders
2.26
Musculoskeletal and connective tissue disorders
2.12
Respiratory, thoracic and mediastinal disorders
2.09

Cross References

Resources Reference
CAS NUMBER 138729-47-2
ChEBI 53760
ChEMBL CHEMBL1522
DrugBank DB00402
DrugCentral 1068
EPA CompTox DTXSID8046086
FDA SRS UZX80K71OE
Human Metabolome Database HMDB0014546
Guide to Pharmacology 7429
KEGG D02624
PharmGKB PA162630444
PubChem 969472
SureChEMBL SCHEMBL28657
ZINC ZINC000019632834